Vivoryon Therapeutics N.V., NL00150002Q7

Vivoryon Therapeutics N.V., NL00150002Q7

23.11.2022 - 07:03:38

EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Successful Listing of 2,054,796 Shares

?

For more information, please contact:

Investor ContactStern IR Julie Seidel Tel: +1 212-698-8684 Email: SternIR-Vivoryon@sternir.com

?

Media ContactTrophic Communications Valeria Fisher Tel: +49 175 8041816 Email:?vivoryon@trophic.eu?

?

Additional features:File: Successful Listing

23.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language: English Company: Vivoryon Therapeutics N.V. Weinbergweg 22 06120 Halle/Saale

Germany Phone: +49 (0)345 555 9900 Fax: +49 (0)345 555 9901 E-mail: contact@vivoryon.com Internet: www.vivoryon.com ISIN: NL00150002Q7 WKN: A2QJV6 Listed: Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart; Amsterdam EQS News ID: 1493991 ? End of News EQS News Service

1493991??23.11.2022?CET/CEST

@ dgap.de